Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

AstraZeneca launches new Zomig formulation for migraine

Sep. 10, 1999

IPA: a potent endogenous antioxidant and neuroprotective agent

Sep. 10, 1999

Acetylcholine releaser SM-21 improves cognitive functions in rats and mice

Sep. 10, 1999

BTS-79018 selected for clinical development as atypical antipsychotic agent

Sep. 9, 1999

New NOS inhibitors in the pipeline at Schering AG

Sep. 9, 1999

D-Pharm's valproic acid derivative completes safety studies

Sep. 8, 1999

Georgetown U discloses new classes of neuroprotective compounds

Sep. 8, 1999

TxA2 synthase inhibitor may have application in SAH

Sep. 8, 1999

N-(Phenylalkyl)cinnamides as structurally novel NR2B-selective NMDA receptor antagonists

Sep. 7, 1999

Plant-derived CNS stimulant and cognition-enhancing agent under study in Brazil

Sep. 6, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026